Symposiums

The main objectives of this symposium were to explore the effect of light on individuals with hyperpigmentation disorders and acne, present the latest…

Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…

Psoriatic arthritis (PsA) and hidradenitis suppurativa (HS) are both immune-mediated diseases with common cellular and cytokine pathways involved in…

The symposium explored new approaches to optimising the value of psoriasis management from the perspective of physicians, patients, and healthcare…

This symposium discussed several recent initiatives used around the world to improve the management of hypertensive patients and achieve better blood…

Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…

The symposium discussed the role of disease modification in alpha-1 antitrypsin deficiency (AATD)-related emphysema. Evidence from the recent RAPID trial…

Prof Helen Reddel opened the symposium by discussing the need to examine the modifiable nonpharmacological factors in the treatment of asthma and chronic…